Author: Jennifer Maggiore Executive Director, NAPT In the realm of cancer treatment, timely access to the most appropriate care is crucial to ensuring improved patient outcomes. However, for many cancer…
Congressional Updates Medicare Payment Rules Released The Centers for Medicare & Medicaid Services (CMS) recently released 2025 proposed Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (OPPS)…
Hampton University Proton Cancer Institute (Hampton Proton) spearheaded a significant effort to expand equitable access to proton therapy in the state of Virginia. Recognizing the potential of proton therapy to…
GUEST CONTRIBUTORS: Jillian Plochocki Executive Director Proton Collaborative Group (PCG) Charles B. Simone, II, MD, FASTRO, FACRO Chief Medical Officer New York Proton Center [minti_divider…
GUEST CONTRIBUTOR: Robert H. Press, MD Radiation Oncologist Baptist Health Miami Cancer Institute Conducting high-quality clinical trials is crucial for establishing the value proposition…
A recent study published in JAMA Network Open highlights significant disparities in travel-time access to proton beam therapy (PBT) for cancer treatment across the contiguous United States. Proton beam therapy,…
Congressional Updates Doc Fix Signed Into Law A “mini-bus” federal funding package signed into law March 9 included the “Doctor Fix,” mitigating Medicare physician payment cuts by 1.68% effective March…
Virginia Attorney General Jason S. Miyares in December issued an opinion confirming that insurers in the Commonwealth are prohibited from denying coverage for proton therapy for cancer treatment when the…
Cancer is a disease where the passage of time can make a difference in treatment outcomes. Recent research underscores the reality that for cancer patients, each week of delay in…
Esophageal cancer incidence in the United States has been on the rise over the past few decades. The American Cancer Society's statistics reveal that in 2022, there were an estimated…
